NYSE:RBOT Vicarious Surgical (RBOT) Stock Forecast, Price & News $0.71 -0.04 (-5.34%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.70▼$0.7750-Day Range$0.71▼$2.0452-Week Range$0.70▼$3.99Volume399,888 shsAverage Volume536,196 shsMarket Capitalization$90.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Vicarious Surgical MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.49% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.41Based on 5 Articles This WeekInsider TradingAcquiring Shares$8 M Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($0.63) to ($0.68) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.98 out of 5 starsMedical Sector601st out of 963 stocksSurgical Appliances & Supplies Industry13th out of 18 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Vicarious Surgical. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.49% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently decreased by 75.61%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RBOT. Previous Next 1.4 News and Social Media Coverage News SentimentVicarious Surgical has a news sentiment score of -0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Vicarious Surgical this week, compared to 1 article on an average week.Search InterestOnly 10 people have searched for RBOT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have bought 6,629.81% more of their company's stock than they have sold. Specifically, they have bought $8,000,000.00 in company stock and sold $118,874.00 in company stock.Percentage Held by Insiders14.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.16% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.63) to ($0.68) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Vicarious Surgical (NYSE:RBOT) StockVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More RBOT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RBOT Stock News HeadlinesSeptember 22, 2023 | finance.yahoo.comVicarious Surgical Receives Continued Listing Standard Notice From NYSESeptember 14, 2023 | msn.comVicarious Surgical (RBOT) to Broaden User Network With New DealSeptember 24, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 8, 2023 | gurufocus.comInsider Sell: Sammy Khalifa Sells 7,094 Shares of Vicarious Surgical Inc (RBOT)September 7, 2023 | finance.yahoo.comVicarious Surgical to Present at the Gilmartin Group Emerging Growth Company ShowcaseSeptember 1, 2023 | finance.yahoo.comVicarious Surgical Inc.'s (NYSE:RBOT) largest shareholders are individual investors with 29% ownership, private equity firms own 25%August 24, 2023 | msn.comVicarious Surgical: Huge Potential But Low Margin Of Safety To CommercializationAugust 7, 2023 | benzinga.comWhy Vicarious Surgical Shares Are Getting HammeredSeptember 24, 2023 | Chaikin Analytics (Ad)Something is Coming for America's Top StockThis stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.August 4, 2023 | proactiveinvestors.comVicarious Surgical stock tanks on discounted public offeringAugust 4, 2023 | seekingalpha.comVicarious Surgical down 17%, prices $45M offeringAugust 3, 2023 | finance.yahoo.comVicarious Surgical to Present at the Canaccord Genuity 43rd Annual Growth ConferenceAugust 3, 2023 | marketwatch.comVicarious Surgical Shares Hit 52-Week Low After Public Offering PricesAugust 3, 2023 | investorplace.comWhy Is Vicarious Surgical (RBOT) Stock Down 41% Today?August 3, 2023 | finance.yahoo.comVicarious Surgical Announces Launch of Proposed Public OfferingJuly 28, 2023 | finance.yahoo.comVicarious Surgical Reports Second Quarter 2023 Financial Results and Announces Clinical Plan and Regulatory IntentJuly 13, 2023 | finance.yahoo.comVicarious Surgical to Report Second Quarter 2023 Financial Results on July 27, 2023June 6, 2023 | finance.yahoo.comIs Vicarious Surgical (NYSE:RBOT) In A Good Position To Deliver On Growth Plans?June 2, 2023 | ca.finance.yahoo.comRBOT - Vicarious Surgical Inc.May 18, 2023 | finance.yahoo.comVicarious Surgical Announces Promotion of John Mazzola to Chief Operating OfficerMay 10, 2023 | finance.yahoo.comBullish Vicarious Surgical Insider Buying Worth US$1.8m Yet To Pay OffMay 8, 2023 | finance.yahoo.comVicarious Surgical Reports First Quarter 2023 Financial ResultsMay 4, 2023 | finance.yahoo.comVicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough AwardsApril 24, 2023 | finance.yahoo.comVicarious Surgical to Report First Quarter 2023 Financial Results on May 8, 2023February 16, 2023 | finance.yahoo.comVicarious Surgical Inc. (NYSE:RBOT) Q4 2022 Earnings Call TranscriptFebruary 14, 2023 | bizjournals.comVicarious Surgical's shares pop following 14% workforce reductionFebruary 14, 2023 | msn.comVicarious Surgical rises after announcing layoffsSee More Headlines Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address RBOT Company Calendar Last Earnings7/27/2023Today9/24/2023Next Earnings (Estimated)11/06/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$5.16 million Net MarginsN/A Pretax MarginN/A Return on Equity-86.43% Return on Assets-64.15% Debt Debt-to-Equity RatioN/A Current Ratio11.39 Quick Ratio11.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.88 per share Price / Book0.81Miscellaneous Outstanding Shares127,300,000Free Float108,552,000Market Cap$90.29 million OptionableOptionable Beta1.18 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key CompetitorsMilestone ScientificNYSE:MLSSInogenNASDAQ:INGNCollPlant BiotechnologiesNASDAQ:CLGNJin Medical InternationalNASDAQ:ZJYLReWalk RoboticsNASDAQ:RWLKView All CompetitorsInsiders & InstitutionsBarclays PLCSold 14,090 shares on 9/21/2023Ownership: 0.011%Adam David SachsSold 4,142 sharesTotal: $3,272.18 ($0.79/share)Sammy KhalifaSold 3,133 sharesTotal: $2,475.07 ($0.79/share)June MorrisSold 1,095 sharesTotal: $865.05 ($0.79/share)William John KellySold 1,107 sharesTotal: $874.53 ($0.79/share)View All Insider TransactionsView All Institutional Transactions RBOT Stock - Frequently Asked Questions How have RBOT shares performed in 2023? Vicarious Surgical's stock was trading at $2.02 at the beginning of 2023. Since then, RBOT shares have decreased by 64.9% and is now trading at $0.7093. View the best growth stocks for 2023 here. Are investors shorting Vicarious Surgical? Vicarious Surgical saw a decrease in short interest in August. As of August 31st, there was short interest totaling 1,900,000 shares, a decrease of 75.6% from the August 15th total of 7,790,000 shares. Based on an average daily volume of 983,100 shares, the days-to-cover ratio is currently 1.9 days. View Vicarious Surgical's Short Interest. When is Vicarious Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023. View our RBOT earnings forecast. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) announced its earnings results on Thursday, July, 27th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.03. What is Vicarious Surgical's stock symbol? Vicarious Surgical trades on the New York Stock Exchange (NYSE) under the ticker symbol "RBOT." Who are Vicarious Surgical's major shareholders? Vicarious Surgical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.02%), DDD Partners LLC (2.29%), State Street Corp (0.92%), Geode Capital Management LLC (0.80%), Northern Trust Corp (0.41%) and Charles Schwab Investment Management Inc. (0.29%). Insiders that own company stock include Adam David Sachs, John Mazzola, June Morris, Philip Liang, Sammy Khalifa, Ventures V LP Khosla and William John Kelly. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Vicarious Surgical's stock price today? One share of RBOT stock can currently be purchased for approximately $0.71. How much money does Vicarious Surgical make? Vicarious Surgical (NYSE:RBOT) has a market capitalization of $90.29 million. The company earns $5.16 million in net income (profit) each year or ($0.62) on an earnings per share basis. How can I contact Vicarious Surgical? Vicarious Surgical's mailing address is 78 Fourth Avenue Waltham, MA 02451. The official website for the company is www.vicarioussurgical.com. The company can be reached via phone at 617 868 1700 or via email at ir@vicarioussurgical.com. This page (NYSE:RBOT) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.